Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Regulation of adipose triglyceride lipase by rosiglitazone.

Liu LF, Purushotham A, Wendel AA, Koba K, DeIuliis J, Lee K, Belury MA.

Diabetes Obes Metab. 2009 Feb;11(2):131-42. doi: 10.1111/j.1463-1326.2008.00916.x. Epub 2008 Jul 17.

2.

PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.

Kershaw EE, Schupp M, Guan HP, Gardner NP, Lazar MA, Flier JS.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1736-45. Epub 2007 Sep 11.

3.

The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma.

Kim JY, Tillison K, Lee JH, Rearick DA, Smas CM.

Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E115-27. Epub 2006 May 16.

4.

Prolonged induction activates Cebpα independent adipogenesis in NIH/3T3 cells.

Shao HY, Hsu HY, Wu KS, Hee SW, Chuang LM, Yeh JI.

PLoS One. 2013;8(1):e51459. doi: 10.1371/journal.pone.0051459. Epub 2013 Jan 10.

5.

6-gingerol inhibits rosiglitazone-induced adipogenesis in 3T3-L1 adipocytes.

Tzeng TF, Chang CJ, Liu IM.

Phytother Res. 2014 Feb;28(2):187-92. doi: 10.1002/ptr.4976. Epub 2013 Mar 21.

PMID:
23519881
6.

Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes.

Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M.

Mol Cell Endocrinol. 2005 Aug 30;240(1-2):43-9.

PMID:
16009485
7.

The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.

Li YY, Wu HS, Tang L, Feng CR, Yu JH, Li Y, Yang YS, Yang B, He QJ.

Pharmacol Res. 2007 Oct;56(4):335-43. Epub 2007 Aug 9.

PMID:
17889553
8.

Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes.

Bonofiglio D, Santoro A, Martello E, Vizza D, Rovito D, Cappello AR, Barone I, Giordano C, Panza S, Catalano S, Iacobazzi V, Dolce V, Andò S.

Biochim Biophys Acta. 2013 Jun;1831(6):1027-36. doi: 10.1016/j.bbalip.2013.01.014. Epub 2013 Jan 28.

PMID:
23370576
9.

Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor.

Tao H, Aakula S, Abumrad NN, Hajri T.

Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E68-79. doi: 10.1152/ajpendo.00367.2009. Epub 2009 Oct 27.

10.

The role of prolyl hydroxylase domain protein (PHD) during rosiglitazone-induced adipocyte differentiation.

Kim J, Kwak HJ, Cha JY, Jeong YS, Rhee SD, Cheon HG.

J Biol Chem. 2014 Jan 31;289(5):2755-64. doi: 10.1074/jbc.M113.493650. Epub 2013 Dec 12.

11.

Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81).

Jeninga EH, Bugge A, Nielsen R, Kersten S, Hamers N, Dani C, Wabitsch M, Berger R, Stunnenberg HG, Mandrup S, Kalkhoven E.

J Biol Chem. 2009 Sep 25;284(39):26385-93. doi: 10.1074/jbc.M109.040741. Epub 2009 Jul 24.

12.

The PPARgamma agonist rosiglitazone enhances rat brown adipose tissue lipogenesis from glucose without altering glucose uptake.

Festuccia WT, Blanchard PG, Turcotte V, Laplante M, Sariahmetoglu M, Brindley DN, Richard D, Deshaies Y.

Am J Physiol Regul Integr Comp Physiol. 2009 May;296(5):R1327-35. doi: 10.1152/ajpregu.91012.2008. Epub 2009 Feb 11.

13.

Higher levels of ATGL are associated with exercise-induced enhancement of lipolysis in rat epididymal adipocytes.

Ogasawara J, Sakurai T, Kizaki T, Ishibashi Y, Izawa T, Sumitani Y, Ishida H, Radak Z, Haga S, Ohno H.

PLoS One. 2012;7(7):e40876. doi: 10.1371/journal.pone.0040876. Epub 2012 Jul 16.

14.

Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin.

Kershaw EE, Hamm JK, Verhagen LA, Peroni O, Katic M, Flier JS.

Diabetes. 2006 Jan;55(1):148-57.

15.

Phytic acid and myo-inositol support adipocyte differentiation and improve insulin sensitivity in 3T3-L1 cells.

Kim JN, Han SN, Kim HK.

Nutr Res. 2014 Aug;34(8):723-31. doi: 10.1016/j.nutres.2014.07.015. Epub 2014 Jul 30.

PMID:
25174657
16.

PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control.

Festuccia WT, Laplante M, Berthiaume M, Gélinas Y, Deshaies Y.

Diabetologia. 2006 Oct;49(10):2427-36. Epub 2006 Aug 14.

PMID:
16906479
17.

Rosiglitazone modulates insulin-induced plasma membrane area changes in single 3T3-L1 adipocytes.

Velebit J, Kovacic PB, Prebil M, Chowdhury HH, Grilc S, Kreft M, Jensen J, Isenović ER, Zorec R.

J Membr Biol. 2008 Jun;223(3):141-9. doi: 10.1007/s00232-008-9120-x. Epub 2008 Aug 27.

PMID:
18754069
18.

A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.

Fujimura T, Kimura C, Oe T, Takata Y, Sakuma H, Aramori I, Mutoh S.

J Pharmacol Exp Ther. 2006 Aug;318(2):863-71. Epub 2006 May 8.

19.

Suppression of adipocyte hypertrophy by polymethoxyflavonoids isolated from Kaempferia parviflora.

Okabe Y, Shimada T, Horikawa T, Kinoshita K, Koyama K, Ichinose K, Aburada M, Takahashi K.

Phytomedicine. 2014 May 15;21(6):800-6. doi: 10.1016/j.phymed.2014.01.014. Epub 2014 Mar 11.

PMID:
24629599
20.

Coprinus comatus cap inhibits adipocyte differentiation via regulation of PPARγ and Akt signaling pathway.

Park HJ, Yun J, Jang SH, Kang SN, Jeon BS, Ko YG, Kim HD, Won CK, Kim GS, Cho JH.

PLoS One. 2014 Sep 2;9(9):e105809. doi: 10.1371/journal.pone.0105809. eCollection 2014.

Items per page

Supplemental Content

Write to the Help Desk